Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-29

Clinical Trial Update: Testosterone Plus Finasteride Treatment After Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating testosterone plus finasteride after spinal cord injury was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINASTERIDE (FINASTERIDE)
  • TESTOSTERONE (testosterone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Spinal Cord Injury, Spinal Cord Injuries | Phase 2 | Status: TERMINATED | Results posted: 2023-09-29